Show simple item record

dc.contributor.authorCooper, Donald P
dc.contributor.authorGriffin, Kathryn A
dc.contributor.authorPovey, Andrew C
dc.date.accessioned2010-08-04T09:54:14Z
dc.date.available2010-08-04T09:54:14Z
dc.date.issued1992-03
dc.identifier.citationImmunoaffinity purification combined with 32P-postlabelling for the detection of O6-methylguanine in DNA from human tissues. 1992, 13 (3):469-75 Carcinogenesisen
dc.identifier.issn0143-3334
dc.identifier.pmid1547539
dc.identifier.doi10.1093/carcin/13.3.469
dc.identifier.urihttp://hdl.handle.net/10541/109027
dc.description.abstractThree different activated supports were used to immobilize alpha-O6-methyldeoxyguanosine (O6-MedG) monoclonal antibody. Affinity gels based on CNBr Sepharose, Affigel Hz and periodate-activated Sepharose (PIAS) were able to bind 1.4, 1.5 and 6.2 nmol [3H]O6-MedG/mg immobilized IgG respectively, and recovery of bound material exceeded 95% in all cases. Significant non-specific binding of normal nucleosides occurred only when using the CNBr gel. PIAS alpha-O6-MedG affinity gel was able to purify O6-MedG-3'-monophosphate from digested synthetic oligonucleotides and in vitro-methylated calf thymus DNA to allow subsequent detection by 32P-postlabelling and two-dimensional TLC. The combined method was applied to three human samples and O6-MedG levels of 0.39, 0.38 and 0.45 mumol/mol 2'-deoxyguanosine were found. The minimum detection limit of the combined method is expected to be approximately 1 O6-MedG in 10(8) normal 2'-deoxyguanosines (i.e. approximately 30 lesions per human cell) when 100 micrograms of DNA is used.
dc.language.isoenen
dc.subject.meshChromatography, Thin Layer
dc.subject.meshDNA
dc.subject.meshGuanine
dc.subject.meshHumans
dc.subject.meshPhosphorus Radioisotopes
dc.titleImmunoaffinity purification combined with 32P-postlabelling for the detection of O6-methylguanine in DNA from human tissues.en
dc.typeArticleen
dc.contributor.departmentCancer Research Campaign Department of Carcinogenesis, Paterson Institute for Cancer Research, Manchester, UK.en
dc.identifier.journalCarcinogenesisen
html.description.abstractThree different activated supports were used to immobilize alpha-O6-methyldeoxyguanosine (O6-MedG) monoclonal antibody. Affinity gels based on CNBr Sepharose, Affigel Hz and periodate-activated Sepharose (PIAS) were able to bind 1.4, 1.5 and 6.2 nmol [3H]O6-MedG/mg immobilized IgG respectively, and recovery of bound material exceeded 95% in all cases. Significant non-specific binding of normal nucleosides occurred only when using the CNBr gel. PIAS alpha-O6-MedG affinity gel was able to purify O6-MedG-3'-monophosphate from digested synthetic oligonucleotides and in vitro-methylated calf thymus DNA to allow subsequent detection by 32P-postlabelling and two-dimensional TLC. The combined method was applied to three human samples and O6-MedG levels of 0.39, 0.38 and 0.45 mumol/mol 2'-deoxyguanosine were found. The minimum detection limit of the combined method is expected to be approximately 1 O6-MedG in 10(8) normal 2'-deoxyguanosines (i.e. approximately 30 lesions per human cell) when 100 micrograms of DNA is used.


This item appears in the following Collection(s)

Show simple item record